Skip to main content

Table 3 Number of subjects and cumulative days of URTI during intervention period

From: Efficacy of heat-killed Lactococcus lactis JCM 5805 on immunity and fatigue during consecutive high intensity exercise in male athletes: a randomized, placebo-controlled, double-blinded trial

  

Symptom positive

Symptom negative

p valuea

Number of subjects (n)

Placebo

13

11

0.768

LC-Plasma

13

13

 

Number of incidences (days)

Placebo

56

256

0.028

LC-Plasmab

39

299

 
  1. Comparison of the cumulative number of subjects and days of URTI
  2. aFor each subjects and incidences were compared between the placebo and LC-Plasma groups by Chi-square test
  3. bThe adjusted residual of the LC-Plasma group (symptom negative) was calculated as 2.3